Cargando…

The MATE trial: a multicentre, mixed-methodology, pilot, randomised controlled trial in neovascular age-related macular degeneration

BACKGROUND/OBJECTIVES: In healthcare research investigating complex interventions, gaps in understanding of processes can be filled by using qualitative methods alongside a quantitative approach. The aim of this mixed-methods pilot trial was to provide feasibility evidence comparing two treatment re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Airody, Archana, Baseler, Heidi A., Seymour, Julie, Allgar, Victoria, Mukherjee, Rajarshi, Downey, Louise, Dhar-Munshi, Sushma, Mahmood, Sajjad, Balaskas, Konstantinos, Empeslidis, Theo, Hanson, Rachel L. W., Dorey, Tracey, Szczerbicki, Tom, Sivaprasad, Sobha, Gale, Richard P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116669/ https://www.ncbi.nlm.nih.gov/pubmed/37081576 http://dx.doi.org/10.1186/s40814-023-01288-0

Ejemplares similares

Optical coherence tomography imaging biomarkers associated with neovascular age-related macular degeneration: a systematic review
por: Hanson, Rachel L. W., et al.
Publicado: (2022)

TANDEM TRIAL: a factorial randomised controlled trial of dose and review schedule of bevacizumab (Avastin) for neovascular macular degeneration in the East Midlands
por: Foss, Alexander, et al.
Publicado: (2020)

Comparing different dosing regimens of bevacizumab in the treatment of neovascular macular degeneration: study protocol for a randomised controlled trial
por: Foss, Alexander JE, et al.
Publicado: (2015)

Role of pegaptanib sodium in the treatment of neovascular age-related macular degeneration
por: Sivaprasad, Sobha
Publicado: (2008)

Cortical Atrophy Predicts Visual Performance in Long-Term Central Retinal Disease; GCL, pRNFL and Cortical Thickness Are Key Biomarkers
por: Hanson, Rachel L. W., et al.
Publicado: (2022)

Pegaptanib sodium for neovascular age-related macular degeneration: clinical experience in the UK
por: Sivaprasad, Sobha, et al.
Publicado: (2008)

Treatment Satisfaction and Well-Being in Patients with Myopic Choroidal Neovascularization Treated with Ranibizumab in the REPAIR Study
por: Amoaku, Winfried M., et al.
Publicado: (2015)

Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update
por: Patel, Praveen J, et al.
Publicado: (2017)

Visual outcome of ranibizumab therapy for neovascular age related macular degeneration in the black population: a report of five cases
por: Vemala, Roopa, et al.
Publicado: (2010)

Patient-reported outcomes in the RELIGHT clinical trial of ranibizumab in diabetic macular oedema
por: Chakravarthy, Usha, et al.
Publicado: (2019)

Diagnostic Accuracy of Monitoring Tests of Fellow Eyes in Patients with Unilateral Neovascular Age-Related Macular Degeneration: Early Detection of Neovascular Age-Related Macular Degeneration Study
por: Sivaprasad, Sobha, et al.
Publicado: (2021)

Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumab
por: Talks, S. James, et al.
Publicado: (2019)

Importance of Anatomical Efficacy for Disease Control in Neovascular AMD: An Expert Opinion
por: Balaskas, Konstantinos, et al.
Publicado: (2021)

Caregiver Burden in Patients Receiving Ranibizumab Therapy for Neovascular Age Related Macular Degeneration
por: Gohil, Rishma, et al.
Publicado: (2015)

Quantitative Autofluorescence in Non-Neovascular Age Related Macular Degeneration
por: Chandra, Shruti, et al.
Publicado: (2023)

Topographical Response of Retinal Neovascularization to Aflibercept or Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: Post Hoc Analysis of the CLARITY Randomized Clinical Trial
por: Halim, Sandra, et al.
Publicado: (2021)

Assessing the structure of the posterior visual pathway in bilateral macular degeneration
por: Brown, Holly D. H., et al.
Publicado: (2023)

Multimodal Imaging in the Management of Choroidal Neovascularization Secondary to Central Serous Chorioretinopathy
por: Hagag, Ahmed M., et al.
Publicado: (2020)

Long-term results of intravitreal bevacizumab and dexamethasone for the treatment of punctate inner choroidopathy associated with choroidal neovascularization: A case series
por: Tsaousis, Konstantinos T, et al.
Publicado: (2018)

A retrospective study of the real-life utilization and effectiveness of ranibizumab therapy for neovascular age-related macular degeneration in the UK
por: Hykin, Philip, et al.
Publicado: (2016)

Treatment satisfaction of patients undergoing ranibizumab therapy for neovascular age-related macular degeneration in a real-life setting
por: Gohil, Rishma, et al.
Publicado: (2016)

The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practice
por: Pearce, Ian, et al.
Publicado: (2022)

Visual acuity outcome of stable proliferative diabetic retinopathy following initial complete panretinal photocoagulation
por: Fu, Dun Jack, et al.
Publicado: (2022)

Intravitreal Ranibizumab in the Treatment of Butterfly-Shaped Pattern Dystrophy Associated with Choroidal Neovascularization: A Case Report
por: Empeslidis, Theodoros, et al.
Publicado: (2012)

Evaluation of real-world early response of DMO to aflibercept therapy to inform future clinical trial design of novel investigational agents
por: Halim, Sandra, et al.
Publicado: (2020)

Editorial on the consensus statement on diabetic retinopathy care pathway
por: Sivaprasad, Sobha
Publicado: (2020)

Tackling diabetic retinopathy from the grassroots
por: Sivaprasad, Sobha
Publicado: (2020)

Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration
por: Chandra, Shruti, et al.
Publicado: (2020)

Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting
por: Eleftheriadou, Maria, et al.
Publicado: (2018)

Recommendations by a UK expert panel on an aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration
por: Ross, Adam H., et al.
Publicado: (2020)

Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
por: Sivaprasad, Sobha, et al.
Publicado: (2016)

A Review of Advancements and Evidence Gaps in Diabetic Retinopathy Screening Models
por: Pearce, Elizabeth, et al.
Publicado: (2020)

Adding screening for “end organ damage” to the noncommunicable disease package in primary care
por: Sadanandan, Rajeev, et al.
Publicado: (2021)

Action on neovascular age-related macular degeneration (nAMD): recommendations for management and service provision in the UK hospital eye service
por: Gale, Richard P., et al.
Publicado: (2019)

Knowledge management and engineering with decisional DNA
por: Szczerbicki, Edward, et al.
Publicado: (2020)

Visual and Anatomical Outcomes of a Single Intravitreal Dexamethasone in Diabetic Macular Edema: An 8 Year Real-World Study
por: Faes, Livia, et al.
Publicado: (2023)

Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial
por: Garweg, Justus G., et al.
Publicado: (2022)

Optic Disc Neovascularization as the Only Sign of Ocular Ischemic Syndrome: A Case Report
por: Metry, Youstina, et al.
Publicado: (2022)

Living Without a Diagnosis: A Patient’s Perspective on Diabetic Macular Ischemia
por: Humphreys, Jacqueline D., et al.
Publicado: (2022)

Key drivers of visual acuity gains in neovascular age-related macular degeneration in real life: findings from the AURA study
por: Holz, Frank G, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o019hrdebm0t3hq6rfrvopegob